Hybrid Closed-Loop (HCL) Therapy for People with Type 1 Diabetes who are Pregnant - NHS England
Автор: CDEP
Загружено: 2024-10-09
Просмотров: 2550
The aim of this webinar is to outline the process and pathways for providing HCL therapy in pregnancy
FOCUS:
1) The NHS 5-year implementation strategy for HCL technologies
2) Maximising the benefits of HCL for women with Type 1 diabetes who are pregnant
3) Practical examples of how maternity services have put HCL onboarding protocols in place
4) Key considerations for ICS leads
SPEAKERS:
1) Eleanor M. Scott (Chair) - Professor of Medicine (Diabetes and Maternal Health), University of Leeds & Leeds Teaching Hospitals Trust
2) Partha Kar - Type 1 Diabetes & Technology Lead. Consultant Diabetes, Portsmouth Hospitals University NHS Trust
3) Helen R. Murphy - Professor of Medicine, University of East Anglia (UEA), Norwich UK, Honorary Consultant Physician, Norfolk & Norwich University NHS Hospital Trust, Chair National Pregnancy in Diabetes (NPID) audit
4) Nina Willer - Diabetes Specialist Midwife, Norfolk & Norwich University NHS Hospital Trust
5) Emma Wilmot – Associate Professor, University of Nottingham School of Medicine, Honorary Consultant Diabetologist, University Hospitals of Derby and Burton. Founder, Diabetes Technology Network UK
6) Karen Kennedy - Assistant Director, National Diabetes Programme, NHS England
Доступные форматы для скачивания:
Скачать видео mp4
-
Информация по загрузке:
